Neuromotus™ nominated for Svea Priset 2019

Report this content

Integrum is proud to announce Neuromotus’ nomination for the Svea Priset 2019. 

‘The nominees have been selected to participate in the final competition for the SveaPriset. They have been selected among 58 submissions under fierce competition, says the Jury of SveaPriset in their press release.’ 

SveaPriset is a yearly award that rewards the best innovation ideas in e-Health towards fulfilling the Swedish Vision for eHealth 2025 which states: In 2025, Sweden will be the best in the world at using the opportunities offered by digitisation and eHealth to make it easier for people to achieve good and equal health and welfare, and to develop and strengthen their own resources for increased independence and participation in the life of society.  

The nominees will present their project on 17th September in Stockholm in front of a jury to demonstrate the great value Neuromotus™ provides to the health economy of Sweden. The winners will be announced at Kvalitetsmässan's opening ceremony at the Göteborg Opera on November 12. 

SveaPriset is supported by Föreningen Sveriges Socialchefer, Socialstyrelsen, Swedish Medtech, Sveriges Kommuner och Landsting, Sveriges Läkarförbund,Vinnova, Vision. Vårdförbundet. Socialdepartementet och Kvalitestsmässan.

For further information, please contact:

Maria Lopez, CEO
Cell. 0708-46 10 69

Certified Adviser:
Erik Penser Bank AB
Tel. +46 8 463 8000

About Integrum

Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRATM implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from 500 surgeries in 14 countries, Integrum is a global leader in bone anchored protheses. The company’s share (INTEG B) is listed for trading on Nasdaq First North in Stockholm with Erik Penser Bank as Certified Advisor. Learn more at


Documents & Links